
Group 2B: HR+ Breast Cancer; Risk Factors
Wednesday, Dec 14
2:00 pm – 3:30 pm Eastern Time (US/New York)
Poster #P3-05-26:
Association of muscle mass and density with outcomes in patients with ER positive metastatic breast cancer: correlative analysis of ECOG-ACRIN 2112
Poster author Tarah Ballinger, M.D. is also the scientist for this session
Poster #P3-01-13:
Palbociclib, ribociclib and abemaciclib in real-world data: risk of disease progression on first-line treatment of metastatic breast cancer
Mentor: Amy Beumer, Ph.D.

Twitter: @amybeumer
Scientist: Tarah Ballinger, M.D.
Dr. Tarah Ballinger’s practice philosophy is to empower her patients to engage in a shared decision-making process with honest discussions at each step of treatment. She feels it is important to individualize care and to focus on the impact of cancer care on a patient as a whole person. Her clinical interests include high-risk and survivor breast oncology, particularly the role of physical activity and exercise. Aside from medicine, Dr. Ballinger enjoys spending time with her family and friends, running and cycling.
Twitter: @TarahBallinger